Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y C Martin

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|April 1, 1974
Discriminant analysis of the relationship between physical properties and the inhibition of monoamine oxidase by aminotetralins and aminoindansY C Martin, J B Holland, C H Jarboe, et al.
Journal of Medicinal Chemistry|April 16, 1993
Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysisA K Debnath, C Hansch, K H Kim, et al.
Journal of Computer-Aided Molecular Design|April 1, 1988
MENTHOR, a database system for the storage and retrieval of three-dimensional molecular structures and associated data searchable by substructural, biologic, physical, or geometric propertiesY C Martin, E B Danaher, C S May, et al.
Journal of Medicinal Chemistry|July 20, 1999
Evaluation of PMF scoring in docking weak ligands to the FK506 binding proteinI Muegge, Y C Martin, P J Hajduk, et al.
Journal of Receptor Research|January 1, 1988
Differentiation of alpha-adrenergic receptors using pharmacological evaluation and molecular modeling of selective adrenergic agentsA A Hancock, J J Kyncl, Y C Martin, et al.
Journal of Pharmaceutical Sciences|August 1, 1990
Inhibitors of immune complex-induced inflammation: 5-substituted 3-[1-(2-benzoxazolyl)hydrazino]propanenitrile derivativesK H Kim, Y C Martin, P R Young, et al.
Progress in Clinical and Biological Research|January 1, 1989
Strategies in drug design based on 3D-structures of ligandsY C Martin, E B Danaher, C S May, et al.
Journal of Pharmaceutical Sciences|March 1, 1994
Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analoguesK H Kim, Y C Martin, D W Brooks, et al.
Journal of Computer-Aided Molecular Design|February 1, 1993
A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonistsY C Martin, M G Bures, E A Danaher, et al.
Journal of Medicinal Chemistry|February 1, 1987
Structural requirements for the inhibition of 5-lipoxygenase by 15-hydroxyeicosa-5,8,11,13-tetraenoic acid analoguesF Haviv, J D Ratajczyk, R W DeNet, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|April 1, 1974
Discriminant analysis of the relationship between physical properties and the inhibition of monoamine oxidase by aminotetralins and aminoindansY C Martin, J B Holland, C H Jarboe, et al.
Journal of Medicinal Chemistry|April 16, 1993
Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysisA K Debnath, C Hansch, K H Kim, et al.
Journal of Computer-Aided Molecular Design|April 1, 1988
MENTHOR, a database system for the storage and retrieval of three-dimensional molecular structures and associated data searchable by substructural, biologic, physical, or geometric propertiesY C Martin, E B Danaher, C S May, et al.
Journal of Medicinal Chemistry|July 20, 1999
Evaluation of PMF scoring in docking weak ligands to the FK506 binding proteinI Muegge, Y C Martin, P J Hajduk, et al.
Journal of Receptor Research|January 1, 1988
Differentiation of alpha-adrenergic receptors using pharmacological evaluation and molecular modeling of selective adrenergic agentsA A Hancock, J J Kyncl, Y C Martin, et al.
Journal of Pharmaceutical Sciences|August 1, 1990
Inhibitors of immune complex-induced inflammation: 5-substituted 3-[1-(2-benzoxazolyl)hydrazino]propanenitrile derivativesK H Kim, Y C Martin, P R Young, et al.
Progress in Clinical and Biological Research|January 1, 1989
Strategies in drug design based on 3D-structures of ligandsY C Martin, E B Danaher, C S May, et al.
Journal of Pharmaceutical Sciences|March 1, 1994
Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analoguesK H Kim, Y C Martin, D W Brooks, et al.
Journal of Computer-Aided Molecular Design|February 1, 1993
A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonistsY C Martin, M G Bures, E A Danaher, et al.
Journal of Medicinal Chemistry|February 1, 1987
Structural requirements for the inhibition of 5-lipoxygenase by 15-hydroxyeicosa-5,8,11,13-tetraenoic acid analoguesF Haviv, J D Ratajczyk, R W DeNet, et al.
Pageof 5